HaemophiliaNCT05138224
Prevalence of Autistic Spectrum Disorder (ASD) in Children With Haemophilia
An observational study of Haemophilia and Autism Spectrum Disorder, run by Great Ormond Street Hospital for Children NHS Foundation Trust.
Trial summary
Parents of children with haemophilia will be invited to complete 3 questionnaires to look for traits present in ASD. With consent teacher will complete a further 2 questionnaires. If all 3 questionnaires are above threshold, then with consent of the family the child will be referred for further investigation. Read more about this study
- Who is it for?
- Ages 5 to 16 years, men only
- Conditions the study is for
- Haemophilia, Autism Spectrum Disorder, Social Communication Disorder
- How many people
- 82 participants
- Where
- No sites listed yet
- Study dates
- Sep 2014to Dec 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 5 to 16 years
- Men only
- Child
Study population: All boys with all severities of haemophilia aged 5-16 years
Who may be able to join
- -All boys with mild, moderate or severe haemophilia will be offered to participate in the questionnaire completion
Who cannot join
- -boys with a pre-existing diagnosis of ASD will be excluded from questionnaire completion but will be included in the prevalence analysis
About this study
Official title: Is There a Higher Prevalence of Autistic Spectrum Disorder (ASD) in Children With Haemophilia (Aged 5-16) Than the General Population?
Parents of children with haemophilia will be invited to complete 3 questionnaires to look for traits present in ASD. With consent teacher will complete a further 2 questionnaires. If all 3 questionnaires are above threshold, then with consent of the family the child will be referred for further investigation.
There are already pre-existing children with ASD who will be exempt from the study, but included in the data analysis of prevalence.
The results of the 3 questionnaires will be used to identify a profile of social communication in children with haemophilia.
Read the detailed description
Background Haemophilia A and B are inherited disorders characterised by spontaneous bleeding. The current treatment is replacement of the deficient factor VIII (FVIII) or factor IX (FIX). Haemophilia occurs in 1:50000 male births and approximately 85% have haemophilia A and approx 15% haemophilia B. Children with haemophilia can be described as having severe, moderate or mild disease dependent on their circulating levels of FVIII or FIX. Children with severe haemophilia are classified as having <1%, moderate 1-5% and mild >5-40%. One third of all children diagnosed with haemophilia have no family history of the bleeding disorder. 80% of bleeding episodes occur in the joints. A bleed into the cranial cavity although rare is called an intracranial haemorrhage (ICH) and outcome can range from neurological impairment (behavioural difficulties) to death (1-2). Bladen et al. 2009 identified behavioural difficulties in a cohort of children at Great Ormond St Hospital for Children NHS Trust with haemophilia following intracranial haemorrhage (3).
Haemophilia and communication difficulties A recent study has highlighted that boys with haemophilia risk attention deficit / hyperactivity disorder (ADHD) spectrum difficulties especially hyperactivity impulsivity (HI) and special education participation (4). No papers could be found detailing a relationship or prevalence of autistic spectrum disorder and haemophilia.
Since the Bladen et al. 2009 publication there has been an increased awareness and diagnosis of boys with autistic spectrum disorder (ASD) at Great Ormond St Hospital for Children NHS Trust haemophilia centre. These problems have required the children to gain statements of special education need in order that they can maximise their educational potential. Children with ASD can also present with motor co-ordination difficulties that increase their risk of falls. This tendency to lack control of their movement may increase bleeding frequency in boys with haemophilia placing them at further risk. It is essential that these boys are screened and identified early so that the necessary additional these children require is attained.
Current literature states that ASD affects approximately 1% of the general population (5-6). Autism-spectrum disorders are diagnosed by the presence of social and communication difficulties, alongside unusually strong, narrow interests and/or repetitive and stereotyped behaviour (7). Language delay and difficulties in cognitive ability are common in children and may extend into below-average range intellectual disabilities. For clinical purposes diagnosis is set at the level where autistic traits are significantly interfering in daily life functioning; currently, there is no biological marker and the diagnosis is established on a basis of a comprehensive assessment of children's behavioural characteristics.
Aim of the study The aim of this study is to use questionnaires to be completed by parents and teachers to screen and assess for difficulties in social interactions, executive functioning, communication and behaviour in boys with haemophilia aged 5-16 .
This research will establish if there is a higher prevalence of symptoms of ASD and executive function difficulties in boys with haemophilia than the general population. This knowledge will assist education management strategies to help those affected boys maximise their educational potential through appropriate schooling support. Highlighting ASD symptoms may aid early diagnosis and facilitate earlier management strategies e.g. a statement of special of educational need if required. The proposed study intends to identify if the increased number of children we have with ASD is an artefact or if indeed there is a higher prevalence of ASD in children with haemophilia. If these findings are substantiated then in the future all children with haemophilia will be screened for ASD as appropriate. Children with above threshold scores on all 3 questionnaire scores would then be referred locally for further psychological assessment and possible diagnosis . All children referred locally for further psychological assessment will be followed up to ascertain if a diagnosis is made as per routine clinical practice. An earlier diagnosis would hopefully ensure that the child and family receive earlier support and maximise the child's potential. It is anticipated that the completion of this study will help improve the overall care and management of boys with haemophilia and autistic spectrum disorder.
Methodology Subjects aged 5-16 years with haemophilia will be identified from Great Ormond St hospital for children NHS Trust haemophilia database. Subjects less than 5 years of age, over 16 years of age, with other bleeding disorders or those already with a diagnosis of ASD will be excluded. The study population is parents of boys with a diagnosis of haemophilia aged 5-16 years of age. It is hoped there will be 100 eligible subjects to take part as the total cohort is 149. Parents of children aged 5-16 years of age will be contacted by letter two weeks before their scheduled haemophilia review (see attached) to invite them to participate in the questionnaire research and they will also be provided with an information leaflet with the invite On attendance at the haemophilia centre if the family agree to participate, consent will be obtained (see attached Parent consent form). This will include consent to contact the child's head teacher, class teacher and the G.P. It is acknowledged that parents may experience increased anxiety whether their child has problems or not and as such it is essential the GP is aware of the family's participation in this study.
For those parents who are unable to read or speak English an interpreter will be provided. Arrangement of an interpreter would be pre-booked for their review appointment as normal. Completion of the form shall be assisted by another member of the team.
Once consent has been obtained, the child's head teacher and class teacher will be contacted with a letter along with a teachers information sheet (see attached) and a copy of the signed consent form. This will inform them of the study and invite them to participate. The class teacher should have known the child for more than 3 months As well as the questionnaires additional information will be gathered from the medical notes and parents, such as birth history, current medication, educational status e.t.c.(for all the items please see attached Additional information sheet) The following questionnaires have been shown to be reliable and valid for screening for children with ASD, The Social Communication Questionnaire, The Childrens Communication Checklist (CCC-2) and the Behaviour Rating Inventory of Executive Function (BRIEF). All questionnaires have normative data for comparison and as such a control group is not required. These 3 will be completed by the parent on the day of the assessment, whilst their child is receiving their routine musculoskeletal assessment. The BRIEF and CCC questionnaires will be sent with the teachers invitation for them to complete. A follow up telephone call will be made to the teacher to discuss any questions they may have .
The Social Communication Questionnaire (SCQ) (8) The SCQ is a brief instrument that can be used to evaluate children over 4 years of age as long as his or her mental age exceeds 2 years of age. The questionnaire takes approximately 10-15 minutes to complete. The questionnaire focuses on behaviours that are rare in non-affected individuals and can be used as a screener for autistic spectrum disorder.
The Social Communication Questionnaire is a 40 item yes/no response parent-report questionnaire that asks about characteristic autistic behaviour. There are 2 forms; the autoscore looking at behaviour in the last 3 months and the lifetime score. The total score is a combination of the autoscore and lifetime score and is interpreted in relation to cut-off scores that indicate the likelihood of an individual having ASD.
The items are scored as either 0 or 1. A score of 1 is an endorsement for each symptom of autism. The range of scores is from 0-39 as the first item the language score is not included in the total score. Nineteen items rate current behaviour and 20 rate behaviour when the child was 4-5 years old. The recommended cut-off score for autistic-spectrum disorder or pervasive developmental disorder is >15. The SCQ has been found to have a high discriminant ability in differentiating ASD symptomatology from other associated behavioural and developmental difficulties. (9).
The Behaviour Rating Inventory of Executive Functioning (BRIEF) (10) Executive functioning is a collection of functions that are responsible for guiding, directing and managing cognitive, emotional and behavioural functions particularly during active, novel problem solving. The term executive function is an umbrella term to describe a collection of inter-related functions that are responsible for purposeful, goal directed problem-solving behaviour.
The BRIEF questionnaire is for parents and teachers of school-aged children that enables professionals to assess executive functioning at home and in the school environments. Answering if any of the statements have applied to the child in the past 6 months. It is designed for children aged 5-18 years of age, and recommended for use with children with a wide range of developmental and neurological conditions, such as ADHD and ASD, who have been identified to be at an increased risk of possible executive function difficulties, including those with learning disabilities, attentional disorders and brain injuries. The questionnaire will take 10- 15 minutes to complete.
The BRIEF contains 86 items within eight theoretically and empirically derived clinical scales that measure and monitor different aspects of executive functioning: inhibit, shift, emotional control, initiate, working memory, plan/organise, organisation of materials.
Inhibit - Assesses inhibitory control i.e. the ability to inhibit, resist or not act on ones impulses.
Shift- Assesses the ability to move freely from one situation or activity or aspect of a problem to another as circumstances demand (problem solving).
Emotional control - Assesses the ability to modulate emotional control i.e. emotional lability or emotional explosiveness.
Initiate - Assesses items relating to beginning a task or activity as well as independently generating ideas, responses or problem solving strategies.
Working memory - Assesses the capacity to hold on to information in mind for the purpose of completing a task. Working memory is essential to carry out multistep activities, complete mental arithmetic or follow complex instructions.
Plan / organise - Assesses the child's ability to manage current and future-orientated tasks. The plan element takes in to consideration an ability to anticipate future events, set goals and set appropriate steps to complete the task. The organise component involves assessing written and oral information to bring order to information and to appreciate the main ideas or concepts.
Organisation of materials - Assesses a child's orderliness of work, play and storage space. This may also take into consideration how order is brought about.
The BRIEF has been shown to have good reliability and validity (10-11). The Childrens Communication Checklist (CCC-2) (12-13) This questionnaire is a 70 item questionnaire which has standard scores and percentiles and can be completed by the parent or teacher The questionnaire asks about language and communication. Scoring an item is broken down into 0 ('does not apply'), 1 ('applies somewhat'), 2 ('definitely applies') or missing value ('unable to judge'). This questionnaire will take approximately 10-15 minutes to complete.
The CCC-2 is divided into 9 subscales: two sub-scales assess aspects of language structure (syntax and speech); two assess aspects of autistic behaviour (social relationships and interests); and five assess aspects of pragmatic communication (inappropriate initiation, coherence, stereotyped conversation, use of context, and rapport), which has been found to be impaired in children with ASD. The raw scores of the subscales are converted to aged scaled scores with a mean of 10 and a std of 3. These aged scaled scores and the GCC are converted to percentiles.
The CCC-2 (12) has a pragmatic composite sub-scale that has been shown to distinguish between those individuals with and without autistic spectrum disorder (14). The CCC-2 has been used in the literature to identify children with communication impairments from non-impaired peers (15). (See attached for copies of the questionnaires proposed) The supervision and scoring of these questionnaires shall be undertaken by Marianna Murin, Clinical Psychologist who works in the social communication team at Great Ormond Street Hospital for Children NHS Trust. The supervision will consist of an initial training session, followed by observed practical sessions. The administration of the questionnaires will be carried out by the primary investigator and Nicola Hubert Physiotherapy colleague.
A score on a screening instrument is indicative of a probable Autism Spectrum Disorder, however it is not sufficient for a formal diagnosis. For diagnostic assessment a full parental interview regarding current and past development and behaviour, and structured observation of the child, preferably including a peer-group setting, is essential. Those children with questionnaire results that suggest further assessment is required will be discussed with Marianna Murin. The family shall be informed by telephone of the concerns raised from the assessment, either by Marianna Murin, the primary investigator or Nicola Hubert physiotherapy colleague. The report will be written and sent to the family. In consultation and consent with the family a referral to a local psychologist via the GP or local paediatrician will be made to facilitate further assessments and establish a diagnosis along with appropriate intervention and support. In the unlikely event of a lost referral / lost letter the primary investigator will follow up all children referred to local services to ensure the referral is received and the outcome of their assessments is known. This would follow current clinical practice. Those children with no indication for ongoing assessment will not receive a report, but a letter that states there is no indication for further investigation.
Results The time scale from invitation to receipt of a letter detailing the outcome of the assessment shall take approximately 6 weeks.
Analyses of the results have been discussed with Angie Wade in the Institute of Child Health.
Previous research within the haemophilia unit has demonstrated a high rate of return with this population group and as such a 5-10% drop out rate is typical of previous studies.
The power calculation provided has considered that some individuals may decline to participate. Based on a sample of 140 out of 149 subjects, we expect at-least 10% to test positive. We would estimate this to + or - 5%. At most we anticipate 33% testing positive and in this case the precision would be + or - 8%. Therefore the sample provides sufficient precision.
The overall results of the study shall be published in a peer review journal. A summary of the overall findings shall be published in the Great Ormond Street Hospital for Children NHS Trust Haemophilia Centre newsletter that is distributed to all families with a child with haemophilia.
Duration of study It is anticipated that data collection will take 1 year and will start in January 2013 and be completed January 2014. Data analysis should be completed by July 2014.
- Conditions
- Haemophilia, Autism Spectrum Disorder, Social Communication Disorder, Attention Deficit Hyperactivity Disorder
- Medical subject headings
- Hemophilia A, Autism Spectrum Disorder, Social Communication Disorder, Attention Deficit Disorder with Hyperactivity
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of autism spectrum disorder in boys with haemophilia at Great Ormond St Hospital
The number of children with a diagnosis of ASD at GOSH
Measured: Within 2 weeks of when the participant consented- measured once
Secondary outcomes (4)
Social Communication Questionnaire
Questionnaire Scores > or equal to 15 will be considered positive
Measured: Within 2 weeks of when the participant consented-measured once
Childrens communication Checklist
Questionnaire Scores < or equal to 132 will be considered positive
Measured: Within 2 weeks of when the participant consented-measured once
BRIEF
Questionnaire Scores on the global executive composite score of > or equal to 65 will be considered positive
Measured: Within 2 weeks of when the participant consented-measured once
Number of children being given a diagnosis of ASD or other following referral for ongoing assessment following positive scores on questionnaires
Children gaining above threshold on the SCQ, CCC and BRIEF and with consent of the family will be referred locally, assessed and the number of children gaining an additional diagnosis will be recorded
Measured: From when study started October 2014 to study end July 2017
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Nov 2021
- Study startSep 2014
- Primary completionAug 2018
- Study completionDec 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (15)Papers the sponsor has linked to this study.
- Other trials for HaemophiliaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 82 participants (actual)
Sponsor and investigators
- Lead sponsor
- Great Ormond Street Hospital for Children NHS Foundation Trust
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05138224
- Sponsor's protocol ID
- 10MH17
- Status last verified
- Nov 2021
- First submitted
- 25 Nov 2020
- Last updated
- 30 Nov 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Kulkarni R, Lusher JM. Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature. J Pediatr Hematol Oncol. 1999 Jul-Aug;21(4):289-95. doi: 10.1097/00043426-199907000-00009.
PubMed 10445891Ljung RC. Intracranial haemorrhage in haemophilia A and B. Br J Haematol. 2008 Feb;140(4):378-84. doi: 10.1111/j.1365-2141.2007.06949.x. Epub 2007 Dec 13.
PubMed 18081890Bladen M, Khair K, Liesner R, Main E. Long-term consequences of intracranial haemorrhage in children with haemophilia. Haemophilia. 2009 Jan;15(1):184-92. doi: 10.1111/j.1365-2516.2008.01815.x. Epub 2008 Aug 13.
PubMed 18702617Spencer ML, Wodrich DL, Schultz W, Wagner L, Recht M. Inattention, hyperactivity-impulsivity, academic skills and psychopathology in boys with and without haemophilia. Haemophilia. 2009 May;15(3):701-6. doi: 10.1111/j.1365-2516.2009.01993.x. Epub 2009 Feb 27.
PubMed 19298375Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D, Charman T. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet. 2006 Jul 15;368(9531):210-5. doi: 10.1016/S0140-6736(06)69041-7.
PubMed 16844490Baron-Cohen S, Scott FJ, Allison C, Williams J, Bolton P, Matthews FE, Brayne C. Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry. 2009 Jun;194(6):500-9. doi: 10.1192/bjp.bp.108.059345.
PubMed 19478287Chandler S, Charman T, Baird G, Simonoff E, Loucas T, Meldrum D, Scott M, Pickles A. Validation of the social communication questionnaire in a population cohort of children with autism spectrum disorders. J Am Acad Child Adolesc Psychiatry. 2007 Oct;46(10):1324-1332. doi: 10.1097/chi.0b013e31812f7d8d.
PubMed 17885574Offord DR, Boyle MH, Racine Y, Szatmari P, Fleming JE, Sanford M, Lipman EL. Integrating assessment data from multiple informants. J Am Acad Child Adolesc Psychiatry. 1996 Aug;35(8):1078-85. doi: 10.1097/00004583-199608000-00019.
PubMed 8755805Bishop DV. Development of the Children's Communication Checklist (CCC): a method for assessing qualitative aspects of communicative impairment in children. J Child Psychol Psychiatry. 1998 Sep;39(6):879-91.
PubMed 9758196Bishop DV, Baird G. Parent and teacher report of pragmatic aspects of communication: use of the children's communication checklist in a clinical setting. Dev Med Child Neurol. 2001 Dec;43(12):809-18. doi: 10.1017/s0012162201001475.
PubMed 11769267Norbury CF, Nash M, Baird G, Bishop D. Using a parental checklist to identify diagnostic groups in children with communication impairment: a validation of the Children's Communication Checklist--2. Int J Lang Commun Disord. 2004 Jul-Sep;39(3):345-64. doi: 10.1080/13682820410001654883.
PubMed 15204445World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. WHO, 1993.
Rutter, M., Bailey, A. & Lord,C. (2003) Social Communication Questionnaire (SCQ).Western Psychological Services.
Gioia, G.A., Isquith, P.K., Guy, S.C., Kenworthy, L. (2000) Behaviour rating inventory of executive functioning Florida: Psychological Assessment Resources Inc.
Bishop DVM. (2003) Children's Communication Checklist Version 2 (CCC2). Psychological Corporation.
Study at a glance
From the registry record, last updated by the sponsor on 30 Nov 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Is There a Higher Prevalence of Autistic Spectrum Disorder (ASD) in Children With Haemophilia (Aged 5-16) Than the General Population?
- ClinicalTrials.gov ID
- NCT05138224
- Acronym / sponsor ID
- 10MH17
- Conditions
- Haemophilia, Autism Spectrum Disorder, Social Communication Disorder, Attention Deficit Hyperactivity Disorder
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 82 participants (actual)
- Lead sponsor
- Great Ormond Street Hospital for Children NHS Foundation TrustUniversity, hospital or other
- Study start
- Sep 2014
- Primary completion
- Aug 2018 (actual)
- Study completion
- Dec 2019 (actual)
- First posted
- 30 Nov 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Parents of children with haemophilia will be invited to complete 3 questionnaires to look for traits present in ASD. With consent teacher will complete a further 2 questionnaires. If all 3 questionnaires are above threshold, then with consent of the family the child will be referred for further investigation.
There are already pre-existing children with ASD who will be exempt from the study, but included in the data analysis of prevalence.
The results of the 3 questionnaires will be used to identify a profile of social communication in children with haemophilia.
Detailed description
Background Haemophilia A and B are inherited disorders characterised by spontaneous bleeding. The current treatment is replacement of the deficient factor VIII (FVIII) or factor IX (FIX). Haemophilia occurs in 1:50000 male births and approximately 85% have haemophilia A and approx 15% haemophilia B. Children with haemophilia can be described as having severe, moderate or mild disease dependent on their circulating levels of FVIII or FIX. Children with severe haemophilia are classified as having <1%, moderate 1-5% and mild >5-40%. One third of all children diagnosed with haemophilia have no family history of the bleeding disorder. 80% of bleeding episodes occur in the joints. A bleed into the cranial cavity although rare is called an intracranial haemorrhage (ICH) and outcome can range from neurological impairment (behavioural difficulties) to death (1-2). Bladen et al. 2009 identified behavioural difficulties in a cohort of children at Great Ormond St Hospital for Children NHS Trust with haemophilia following intracranial haemorrhage (3).
Haemophilia and communication difficulties A recent study has highlighted that boys with haemophilia risk attention deficit / hyperactivity disorder (ADHD) spectrum difficulties especially hyperactivity impulsivity (HI) and special education participation (4). No papers could be found detailing a relationship or prevalence of autistic spectrum disorder and haemophilia.
Since the Bladen et al. 2009 publication there has been an increased awareness and diagnosis of boys with autistic spectrum disorder (ASD) at Great Ormond St Hospital for Children NHS Trust haemophilia centre. These problems have required the children to gain statements of special education need in order that they can maximise their educational potential. Children with ASD can also present with motor co-ordination difficulties that increase their risk of falls. This tendency to lack control of their movement may increase bleeding frequency in boys with haemophilia placing them at further risk. It is essential that these boys are screened and identified early so that the necessary additional these children require is attained.
Current literature states that ASD affects approximately 1% of the general population (5-6). Autism-spectrum disorders are diagnosed by the presence of social and communication difficulties, alongside unusually strong, narrow interests and/or repetitive and stereotyped behaviour (7). Language delay and difficulties in cognitive ability are common in children and may extend into below-average range intellectual disabilities. For clinical purposes diagnosis is set at the level where autistic traits are significantly interfering in daily life functioning; currently, there is no biological marker and the diagnosis is established on a basis of a comprehensive assessment of children's behavioural characteristics.
Aim of the study The aim of this study is to use questionnaires to be completed by parents and teachers to screen and assess for difficulties in social interactions, executive functioning, communication and behaviour in boys with haemophilia aged 5-16 .
This research will establish if there is a higher prevalence of symptoms of ASD and executive function difficulties in boys with haemophilia than the general population. This knowledge will assist education management strategies to help those affected boys maximise their educational potential through appropriate schooling support. Highlighting ASD symptoms may aid early diagnosis and facilitate earlier management strategies e.g. a statement of special of educational need if required. The proposed study intends to identify if the increased number of children we have with ASD is an artefact or if indeed there is a higher prevalence of ASD in children with haemophilia. If these findings are substantiated then in the future all children with haemophilia will be screened for ASD as appropriate. Children with above threshold scores on all 3 questionnaire scores would then be referred locally for further psychological assessment and possible diagnosis . All children referred locally for further psychological assessment will be followed up to ascertain if a diagnosis is made as per routine clinical practice. An earlier diagnosis would hopefully ensure that the child and family receive earlier support and maximise the child's potential. It is anticipated that the completion of this study will help improve the overall care and management of boys with haemophilia and autistic spectrum disorder.
Methodology Subjects aged 5-16 years with haemophilia will be identified from Great Ormond St hospital for children NHS Trust haemophilia database. Subjects less than 5 years of age, over 16 years of age, with other bleeding disorders or those already with a diagnosis of ASD will be excluded. The study population is parents of boys with a diagnosis of haemophilia aged 5-16 years of age. It is hoped there will be 100 eligible subjects to take part as the total cohort is 149. Parents of children aged 5-16 years of age will be contacted by letter two weeks before their scheduled haemophilia review (see attached) to invite them to participate in the questionnaire research and they will also be provided with an information leaflet with the invite On attendance at the haemophilia centre if the family agree to participate, consent will be obtained (see attached Parent consent form). This will include consent to contact the child's head teacher, class teacher and the G.P. It is acknowledged that parents may experience increased anxiety whether their child has problems or not and as such it is essential the GP is aware of the family's participation in this study.
For those parents who are unable to read or speak English an interpreter will be provided. Arrangement of an interpreter would be pre-booked for their review appointment as normal. Completion of the form shall be assisted by another member of the team.
Once consent has been obtained, the child's head teacher and class teacher will be contacted with a letter along with a teachers information sheet (see attached) and a copy of the signed consent form. This will inform them of the study and invite them to participate. The class teacher should have known the child for more than 3 months As well as the questionnaires additional information will be gathered from the medical notes and parents, such as birth history, current medication, educational status e.t.c.(for all the items please see attached Additional information sheet) The following questionnaires have been shown to be reliable and valid for screening for children with ASD, The Social Communication Questionnaire, The Childrens Communication Checklist (CCC-2) and the Behaviour Rating Inventory of Executive Function (BRIEF). All questionnaires have normative data for comparison and as such a control group is not required. These 3 will be completed by the parent on the day of the assessment, whilst their child is receiving their routine musculoskeletal assessment. The BRIEF and CCC questionnaires will be sent with the teachers invitation for them to complete. A follow up telephone call will be made to the teacher to discuss any questions they may have .
The Social Communication Questionnaire (SCQ) (8) The SCQ is a brief instrument that can be used to evaluate children over 4 years of age as long as his or her mental age exceeds 2 years of age. The questionnaire takes approximately 10-15 minutes to complete. The questionnaire focuses on behaviours that are rare in non-affected individuals and can be used as a screener for autistic spectrum disorder.
The Social Communication Questionnaire is a 40 item yes/no response parent-report questionnaire that asks about characteristic autistic behaviour. There are 2 forms; the autoscore looking at behaviour in the last 3 months and the lifetime score. The total score is a combination of the autoscore and lifetime score and is interpreted in relation to cut-off scores that indicate the likelihood of an individual having ASD.
The items are scored as either 0 or 1. A score of 1 is an endorsement for each symptom of autism. The range of scores is from 0-39 as the first item the language score is not included in the total score. Nineteen items rate current behaviour and 20 rate behaviour when the child was 4-5 years old. The recommended cut-off score for autistic-spectrum disorder or pervasive developmental disorder is >15. The SCQ has been found to have a high discriminant ability in differentiating ASD symptomatology from other associated behavioural and developmental difficulties. (9).
The Behaviour Rating Inventory of Executive Functioning (BRIEF) (10) Executive functioning is a collection of functions that are responsible for guiding, directing and managing cognitive, emotional and behavioural functions particularly during active, novel problem solving. The term executive function is an umbrella term to describe a collection of inter-related functions that are responsible for purposeful, goal directed problem-solving behaviour.
The BRIEF questionnaire is for parents and teachers of school-aged children that enables professionals to assess executive functioning at home and in the school environments. Answering if any of the statements have applied to the child in the past 6 months. It is designed for children aged 5-18 years of age, and recommended for use with children with a wide range of developmental and neurological conditions, such as ADHD and ASD, who have been identified to be at an increased risk of possible executive function difficulties, including those with learning disabilities, attentional disorders and brain injuries. The questionnaire will take 10- 15 minutes to complete.
The BRIEF contains 86 items within eight theoretically and empirically derived clinical scales that measure and monitor different aspects of executive functioning: inhibit, shift, emotional control, initiate, working memory, plan/organise, organisation of materials.
Inhibit - Assesses inhibitory control i.e. the ability to inhibit, resist or not act on ones impulses.
Shift- Assesses the ability to move freely from one situation or activity or aspect of a problem to another as circumstances demand (problem solving).
Emotional control - Assesses the ability to modulate emotional control i.e. emotional lability or emotional explosiveness.
Initiate - Assesses items relating to beginning a task or activity as well as independently generating ideas, responses or problem solving strategies.
Working memory - Assesses the capacity to hold on to information in mind for the purpose of completing a task. Working memory is essential to carry out multistep activities, complete mental arithmetic or follow complex instructions.
Plan / organise - Assesses the child's ability to manage current and future-orientated tasks. The plan element takes in to consideration an ability to anticipate future events, set goals and set appropriate steps to complete the task. The organise component involves assessing written and oral information to bring order to information and to appreciate the main ideas or concepts.
Organisation of materials - Assesses a child's orderliness of work, play and storage space. This may also take into consideration how order is brought about.
The BRIEF has been shown to have good reliability and validity (10-11). The Childrens Communication Checklist (CCC-2) (12-13) This questionnaire is a 70 item questionnaire which has standard scores and percentiles and can be completed by the parent or teacher The questionnaire asks about language and communication. Scoring an item is broken down into 0 ('does not apply'), 1 ('applies somewhat'), 2 ('definitely applies') or missing value ('unable to judge'). This questionnaire will take approximately 10-15 minutes to complete.
The CCC-2 is divided into 9 subscales: two sub-scales assess aspects of language structure (syntax and speech); two assess aspects of autistic behaviour (social relationships and interests); and five assess aspects of pragmatic communication (inappropriate initiation, coherence, stereotyped conversation, use of context, and rapport), which has been found to be impaired in children with ASD. The raw scores of the subscales are converted to aged scaled scores with a mean of 10 and a std of 3. These aged scaled scores and the GCC are converted to percentiles.
The CCC-2 (12) has a pragmatic composite sub-scale that has been shown to distinguish between those individuals with and without autistic spectrum disorder (14). The CCC-2 has been used in the literature to identify children with communication impairments from non-impaired peers (15). (See attached for copies of the questionnaires proposed) The supervision and scoring of these questionnaires shall be undertaken by Marianna Murin, Clinical Psychologist who works in the social communication team at Great Ormond Street Hospital for Children NHS Trust. The supervision will consist of an initial training session, followed by observed practical sessions. The administration of the questionnaires will be carried out by the primary investigator and Nicola Hubert Physiotherapy colleague.
A score on a screening instrument is indicative of a probable Autism Spectrum Disorder, however it is not sufficient for a formal diagnosis. For diagnostic assessment a full parental interview regarding current and past development and behaviour, and structured observation of the child, preferably including a peer-group setting, is essential. Those children with questionnaire results that suggest further assessment is required will be discussed with Marianna Murin. The family shall be informed by telephone of the concerns raised from the assessment, either by Marianna Murin, the primary investigator or Nicola Hubert physiotherapy colleague. The report will be written and sent to the family. In consultation and consent with the family a referral to a local psychologist via the GP or local paediatrician will be made to facilitate further assessments and establish a diagnosis along with appropriate intervention and support. In the unlikely event of a lost referral / lost letter the primary investigator will follow up all children referred to local services to ensure the referral is received and the outcome of their assessments is known. This would follow current clinical practice. Those children with no indication for ongoing assessment will not receive a report, but a letter that states there is no indication for further investigation.
Results The time scale from invitation to receipt of a letter detailing the outcome of the assessment shall take approximately 6 weeks.
Analyses of the results have been discussed with Angie Wade in the Institute of Child Health.
Previous research within the haemophilia unit has demonstrated a high rate of return with this population group and as such a 5-10% drop out rate is typical of previous studies.
The power calculation provided has considered that some individuals may decline to participate. Based on a sample of 140 out of 149 subjects, we expect at-least 10% to test positive. We would estimate this to + or - 5%. At most we anticipate 33% testing positive and in this case the precision would be + or - 8%. Therefore the sample provides sufficient precision.
The overall results of the study shall be published in a peer review journal. A summary of the overall findings shall be published in the Great Ormond Street Hospital for Children NHS Trust Haemophilia Centre newsletter that is distributed to all families with a child with haemophilia.
Duration of study It is anticipated that data collection will take 1 year and will start in January 2013 and be completed January 2014. Data analysis should be completed by July 2014.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 5 to 16 years
- Sex
- Male only
- Age groups
- Child
- Study population
- All boys with all severities of haemophilia aged 5-16 years
Key inclusion criteria (1 listed)
- -All boys with mild, moderate or severe haemophilia will be offered to participate in the questionnaire completion
Key exclusion criteria (1 listed)
- -boys with a pre-existing diagnosis of ASD will be excluded from questionnaire completion but will be included in the prevalence analysis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Prevalence of autism spectrum disorder in boys with haemophilia at Great Ormond St Hospital
Time frame: Within 2 weeks of when the participant consented- measured once
The number of children with a diagnosis of ASD at GOSH
4 secondary outcomes
Social Communication Questionnaire
Time frame: Within 2 weeks of when the participant consented-measured once
Childrens communication Checklist
Time frame: Within 2 weeks of when the participant consented-measured once
BRIEF
Time frame: Within 2 weeks of when the participant consented-measured once
Number of children being given a diagnosis of ASD or other following referral for ongoing assessment following positive scores on questionnaires
Time frame: From when study started October 2014 to study end July 2017
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Nov 2021.
- Background: PubMed 10445891Kulkarni R, Lusher JM. Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature. J Pediatr Hematol Oncol. 1999 Jul-Aug;21(4):289-95. doi: 10.1097/00043426-199907000-00009.
- Background: PubMed 18081890Ljung RC. Intracranial haemorrhage in haemophilia A and B. Br J Haematol. 2008 Feb;140(4):378-84. doi: 10.1111/j.1365-2141.2007.06949.x. Epub 2007 Dec 13.
- Background: PubMed 18702617Bladen M, Khair K, Liesner R, Main E. Long-term consequences of intracranial haemorrhage in children with haemophilia. Haemophilia. 2009 Jan;15(1):184-92. doi: 10.1111/j.1365-2516.2008.01815.x. Epub 2008 Aug 13.
- Background: PubMed 19298375Spencer ML, Wodrich DL, Schultz W, Wagner L, Recht M. Inattention, hyperactivity-impulsivity, academic skills and psychopathology in boys with and without haemophilia. Haemophilia. 2009 May;15(3):701-6. doi: 10.1111/j.1365-2516.2009.01993.x. Epub 2009 Feb 27.
- Background: PubMed 16844490Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D, Charman T. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet. 2006 Jul 15;368(9531):210-5. doi: 10.1016/S0140-6736(06)69041-7.
- Background: PubMed 19478287Baron-Cohen S, Scott FJ, Allison C, Williams J, Bolton P, Matthews FE, Brayne C. Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry. 2009 Jun;194(6):500-9. doi: 10.1192/bjp.bp.108.059345.
- Background: PubMed 17885574Chandler S, Charman T, Baird G, Simonoff E, Loucas T, Meldrum D, Scott M, Pickles A. Validation of the social communication questionnaire in a population cohort of children with autism spectrum disorders. J Am Acad Child Adolesc Psychiatry. 2007 Oct;46(10):1324-1332. doi: 10.1097/chi.0b013e31812f7d8d.
- Background: PubMed 8755805Offord DR, Boyle MH, Racine Y, Szatmari P, Fleming JE, Sanford M, Lipman EL. Integrating assessment data from multiple informants. J Am Acad Child Adolesc Psychiatry. 1996 Aug;35(8):1078-85. doi: 10.1097/00004583-199608000-00019.
- Background: PubMed 9758196Bishop DV. Development of the Children's Communication Checklist (CCC): a method for assessing qualitative aspects of communicative impairment in children. J Child Psychol Psychiatry. 1998 Sep;39(6):879-91.
- Background: PubMed 11769267Bishop DV, Baird G. Parent and teacher report of pragmatic aspects of communication: use of the children's communication checklist in a clinical setting. Dev Med Child Neurol. 2001 Dec;43(12):809-18. doi: 10.1017/s0012162201001475.
- Background: PubMed 15204445Norbury CF, Nash M, Baird G, Bishop D. Using a parental checklist to identify diagnostic groups in children with communication impairment: a validation of the Children's Communication Checklist--2. Int J Lang Commun Disord. 2004 Jul-Sep;39(3):345-64. doi: 10.1080/13682820410001654883.
- BackgroundWorld Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. WHO, 1993.
Related trials for Haemophilia
RecruitingObservational study
The CACHE Study: Coronary Artery Care in HaEmophilia
Haemophilia, Cardiovascular Diseases
Active, not recruitingObservational study
A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.
Hemophilia A or B
RecruitingPhase 1/2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Hemophilia A
Active, not recruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B
Hemophilia B
Not yet recruiting
Safety of Intraosseous Anaesthesia in Children With Haemophilia
Haemophilia A, Haemophilia B
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Haemophilia and Autism Spectrum Disorder, run by Great Ormond Street Hospital for Children NHS Foundation Trust.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of autism spectrum disorder in boys with haemophilia at Great Ormond St Hospital (time frame: Within 2 weeks of when the participant consented- measured once). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05138224, which also lists 15 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2021.